Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1208-1211

  Lin, Shee Chan ^a   Shih, Shou Chuan ^a   Kao, Chin Roa ^a   Chou, Sun Yen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK; STATISTICAL ANALYSIS; THORAX RADIOGRAPHY; TUMOR VOLUME;

EID: 0038052657     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1208     Document Type: Article

References (26)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129-1133
2. Rustgi V. Epidemiology of hepatocellular cancer. Ann Intern Med 1988; 108: 390-397
3. Curley SA, Levin B, Rich TA. Liver and bile ducts. In: Abeloff MD, Armitage JO, Lichter AS. eds. Clinical Oncology. New York: Churchill Livingstone, Inc, 1995: 1305-1372
4. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, Yukaya H. Liver resection for hepatocellular carcinoma: Results of 29 consecutive patients during 11 years. Ann Surg 1993; 217: 375-384
5. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-391
6. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992; 69: 925-929
7. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference: Hepatocellular carcinoma. Ann Intern Med 1988; 108: 390-401
8. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985; 56: 918-928
9. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401
10. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Ideo G. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors. Hepatology 1994; 19: 1115-1123
11. Hsieh MY, Chang WY, Wang LY, Chen SC, Chuang WL, Lu SN, Wu DK. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemotherapy & Pharmacology 1992; 31: S82-85
12. Yoshimi F, Nagao T, Inoue S, Kawano N, Muto T, Gunji T, Ohnishi S, Imawari M. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: Necessity for prospective randomized trial. Hepatology 1992; 16: 702-706
13. Bonfil RD, Bustuoabad OD, Ruggiero RA, Meiss RP, Pasqualini CD. Tumor necrosis can facilitate the appearance of metastasis. Clin Exp Metastasis 1988; 6: 121-129
14. Lee YT, Geer DA. Primary liver cancer: Pattern of metastasis. J Surg Oncol 1987; 36: 26-31
15. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995; 23: 563-568
16. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977; 35: 1-39
17. Hashimoto N, Kobayashi M, Tsuji T. Serum type IV collagen-degrading enzyme in hepatocellular carcinoma with metastasis. Acta Med Okayama 1988; 42: 1-6
18. Isoai A, Giga-Hama Y, Shinkai K, Mukai M, Akedo H, Kumagai H. Tumor invasion-inhibiting factor 2: Primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells. Cancer Res 1992; 52: 1422-1426
19. Boix L, Bruix J, Castells A. Circulating mRNA for alpha-fetoprotein in patients with hepatocellular carcinoma. Evidence of tumor dissemination after transarterial embolization. Hepatology 1996; 24: 349
20. Peters RL. Pathology of hepatocellular carcinoma. Okuda K, Peters, RL, eds. Hepatocellular Carcinoma. New York: John Wiley & Son Inc, 1976: 107-168
21. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, Peng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Br J Surg 1995; 82: 122-126
22. Sawabe M, Nakamura T, Kanno J, Kasuga T. Analysis of morphological factors of hepatocellular carcinoma in 98 autopsy cases with respect to pulmonary metastasis. Acta Pathol Jpn 1987; 37: 1389-1404
23. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988; 48: 7314-7318
24. Sheu JC, Chen DS, Sung JL, Chuang CN, Yang PM, Lin JT, Yang PC. Hepatocellular carcinoma: US evolution in the early stage. Radiology 1985; 155: 463-467
25. Yang R, Kopecky KK, Rescorla FJ, Galliani CA, Grosfeld JL. Changes of hepatoma echo patterns with tumor growth. A study of the microanatomic basis in a rat model. Invest Radiol 1993; 28: 507-512
26. Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res 1990; 49: 927-97